This excerpt taken from the CXSP 20-F filed Dec 30, 2008.
Dr Greg Collier B.Sc (Hons) PhD (Chief Executive Officer and Managing Director)
Dr. Collier is one of Australias leading biotechnology executives, and is credited with leading the transformation of the former Australian genomics company Autogen into the integrated international biopharmaceutical company ChemGenex Pharmaceuticals. As CEO of the company, Dr. Collier has overseen the partnering of major research programs, the $14 million acquisition of a private US biotechnology company and listing of the companys securities on the NASDAQ exchange. Dr. Collier is recognised internationally as a leader who has guided his company along a value-creating path towards marketed products, and is a regular invited speaker at international research and biotechnology conferences. Age 50.